MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from atm
offering
$19,469K
Net cash provided by
(used in) financing...
$17,775K
Effect of foreign
exchange rates on cash and...
$201K
Canceled cashflow
$1,694K
Net decrease in
cash, cash...
-$393,372K
Canceled cashflow
$17,976K
Maturities of marketable
debt securities
$159,483K
Proceeds from sale of
marketable debt securities
$25,899K
Proceeds from sale of
equipment
$574K
Other
-$50K
Stock-based compensation
$81,546K
Depreciation and
amortization
$58,990K
Non-cash lease expense
$30,082K
Loss on investments
-$16,411K
Other non-current
liabilities
$11,463K
Accrued expenses and
other current...
$10,376K
Change in fair value of
notes receivable
$5,685K
Operating lease
right-of-use assets
-$3,814K
Other non-cash
activity
-$2,064K
Other non-current
assets
-$296K
Payment of issuance
costs related to atm...
$1,340K
Principal payments on
finance leases
$354K
Net cash used in
investing activities
-$240,289K
Net cash used in
operating activities
-$171,059K
Canceled cashflow
$186,006K
Canceled cashflow
$220,727K
Purchases of marketable
debt securities
$418,630K
Net loss
-$312,763K
Purchases of property and
equipment
$7,665K
Deferred revenue,
current and non-current...
-$32,393K
Operating lease
liabilities, current and...
-$27,932K
Prepaid expenses and
other current assets
$5,247K
Change in fair value of
contingent consideration...
$4,232K
Accretion of discount on
marketable securities
$3,390K
Accounts payable
-$2,992K
Accounts receivable
(357, 156 and 816 from...
$1,473K
Deferred income tax
benefit
-$1,364K
Back
Back
Cash Flow
source: myfinsight.com
Ginkgo Bioworks Holdings, Inc. (DNABW)
Ginkgo Bioworks Holdings, Inc. (DNABW)